This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Terns Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Olivia D. Teal: Innovator in GLP-1R and THRβ Agonist Combinations
Introduction
Olivia D. Teal is a prominent inventor based in Cardiff, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative combinations of glucagon-like peptide-1 receptor (GLP-1R) agonists and thyroid hormone receptor beta (THRβ) agonists. Her work aims to provide effective methods for administering these combinations to subjects in need.
Latest Patents
Olivia holds a patent for her invention titled "Combinations of GLP-1R and THRβ agonists and methods of use thereof." This patent outlines the unique combinations of GLP-1R and THRβ agonists and the methods for their administration, showcasing her expertise in this specialized area. She has been awarded 1 patent for her innovative work.
Career Highlights
Olivia is currently employed at Terns Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other talented professionals in the field, contributing to the growth of innovative therapeutic solutions.
Collaborations
Among her notable coworkers are Christopher T. Jones and Jeffrey R. Jasper, who work alongside her at Terns Pharmaceuticals, Inc. Their collaboration fosters a dynamic environment for innovation and research.
Conclusion
Olivia D. Teal is a dedicated inventor whose work in GLP-1R and THRβ agonist combinations is paving the way for new therapeutic methods. Her contributions to the pharmaceutical industry are noteworthy and reflect her commitment to improving patient care.